The annual call for new topics is open.
To propose a new health condition that is not already considered by the UK NSC, please follow this link.
The deadline for submissions is midnight on Wednesday 6th December. More info
 

The UK NSC recommendation on HTLV (human t-cell lymphotrophic virus) screening in pregnancy (currently under review)

 

This recommendation is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in Dec 2016 and is estimated to be completed by Dec 2017.

Recommendation Systematic population screening programme not recommended
 
Key downloads
 

Find general information about population health screening.

More about HTLV

HTLV1 is a retrovirus (like HIV) affecting the immune system. It is associated with a particular leukemia/lymphoma but most people have no symptoms.

» Read more about lymphoma and HTLV1 on NHS Choices

Stakeholders

British Society for Immunology
Faculty of Public Health
National Centre for Human Retrovirology
Royal College of General Practitioners
Royal College of Obstetricians and Gynaecologists
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

Related documents

icon Review of HTLV-1 against UK NSC criteria Jan 2012 (PDF document, 55KB, 28/06/17)

More options

Go to top